Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco

<table class="fixed-width table-group" id="tab2"><tr><td><table class="table"><colgroup><col style="width:9.87em"/><col style="width:2.52em"/><col style="width:5.69em"/></colgroup><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left"><b>Immunological tests</b></td><td class="align_center"><b>No</b></td><td class="align_center"><b>Frequency</b></td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">ANA</td><td class="align_center">44</td><td class="align_center">88%</td></tr><tr><td class="align_left">Anti-DNA</td><td class="align_center">28</td><td class="align_center">56%</td></tr><tr><td class="align_left">Anti-Sm</td><td class="align_center">25</td><td class="align_center">50%</td></tr><tr><td class="align_left">Anti-SSA</td><td class="align_center">19</td><td class="align_center">38%</td></tr><tr><td class="align_left">Anti-SSB</td><td class="align_center">5</td><td class="align_center">10%</td></tr><tr><td class="align_left">Anti-Sm/RNP</td><td class="align_center">24</td><td class="align_center">48%</td></tr><tr><td class="align_left">Anti-Scl70</td><td class="align_center">4</td><td class="align_center">8%</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The main autoantibodies in 50 SLE patients.</div>

BioMed Research International

tab2

Table 2

Table 2: Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco 